Drug Development Pharmaceutical Companies Webinar 
pharmaphorum
DECEMBER 21, 2021
However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. The potential to leverage genomic data.
Pharmaceutical Technology
OCTOBER 26, 2022
Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
AUGUST 15, 2024
In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD). Let’s break them down below.
Viseven
NOVEMBER 9, 2022
Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. It’s about finding HCP leaders with the most influence within the pharmaceutical industry. Conclusion.
Pharmaceutical Technology
MARCH 22, 2023
Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile. Please check your email to download the Webinar.
Expert insights. Personalized for you.
98 
Let's personalize your content